Relapse-like behavior and nAChR sensitization following intermittent access nicotine self-administration.

Neuropharmacology 2022 Jul 01

filter terms:

Many tobacco smokers consume nicotine intermittently, but the underlying mechanisms and neurobiological changes associated with intermittent nicotine intake are unclear. Understanding intermittent nicotine intake is a high priority, as it could promote therapeutic strategies to attenuate tobacco consumption. We examined nicotine intake behavior and neurobiological changes in male rats that were trained to self-administer nicotine during brief (5 min) trials interspersed with longer (15 min) drug-free periods. Rats readily adapted to intermittent access (IntA) SA following acquisition on a continuous access (ContA) schedule. Probabilistic analysis of IntA nicotine SA suggested reduced nicotine loading behavior compared to ContA, and nicotine pharmacokinetic modeling revealed that rats taking nicotine intermittently may have increased intake to maintain blood levels of nicotine that are comparable to ContA SA. After IntA nicotine SA, rats exhibited an increase in unreinforced responses for nicotine-associated cues (incubation of craving) and specific alterations in the striatal proteome after 7 days without nicotine. IntA nicotine SA also induced nAChR functional upregulation in the interpeduncular nucleus (IPN), and it enhanced nicotine binding in the brain as determined via [11C]nicotine positron emission tomography. Reducing the saliency of the cue conditions during the 5 min access periods attenuated nicotine intake, but incubation of craving was preserved. Together, these results indicate that IntA conditions promote nicotine SA and nicotine seeking after a nicotine-free period. Copyright © 2022 Elsevier Ltd. All rights reserved.

Citation

Melissa A Tapia, Xiao-Tao Jin, Brenton R Tucker, Leanne N Thomas, Noah B Walker, Veronica J Kim, Steven E Albertson, Naresh Damuka, Ivan Krizan, Seby Edassery, Jeffrey N Savas, Kiran Kumar Solingapuram Sai, Sara R Jones, Ryan M Drenan. Relapse-like behavior and nAChR sensitization following intermittent access nicotine self-administration. Neuropharmacology. 2022 Jul 01;212:109066